Envista Holdings Co. (NYSE:NVST – Free Report) – Investment analysts at Leerink Partnrs increased their FY2027 EPS estimates for shares of Envista in a research report issued on Monday, October 14th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $1.52 per share for the year, up from their prior estimate of $1.51. The consensus estimate for Envista’s current full-year earnings is $0.69 per share.
Several other research firms have also recently weighed in on NVST. Bank of America cut their price target on shares of Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 8th. JPMorgan Chase & Co. lowered shares of Envista from an “overweight” rating to a “neutral” rating and cut their target price for the company from $23.00 to $16.00 in a research note on Thursday, August 8th. Evercore ISI increased their price target on shares of Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Piper Sandler cut their price objective on Envista from $18.00 to $16.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 30th. Finally, Stifel Nicolaus decreased their target price on Envista from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Tuesday, July 30th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Envista has an average rating of “Hold” and an average target price of $19.63.
Envista Stock Up 2.7 %
Shares of NYSE:NVST opened at $18.18 on Thursday. The stock has a market capitalization of $3.12 billion, a P/E ratio of -25.25 and a beta of 1.32. The stock’s 50-day moving average price is $18.23 and its 200-day moving average price is $18.15. The company has a current ratio of 2.22, a quick ratio of 1.90 and a debt-to-equity ratio of 0.47. Envista has a 12-month low of $15.15 and a 12-month high of $25.64.
Envista (NYSE:NVST – Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.16). Envista had a negative net margin of 52.25% and a positive return on equity of 4.86%. The business had revenue of $633.10 million for the quarter, compared to the consensus estimate of $646.88 million. During the same quarter last year, the business posted $0.43 EPS. The business’s revenue was down 4.4% compared to the same quarter last year.
Institutional Investors Weigh In On Envista
Several institutional investors and hedge funds have recently made changes to their positions in NVST. Jupiter Asset Management Ltd. purchased a new stake in Envista during the 2nd quarter valued at $69,534,000. Pacer Advisors Inc. boosted its position in shares of Envista by 11,202.8% during the second quarter. Pacer Advisors Inc. now owns 2,887,426 shares of the company’s stock valued at $48,018,000 after buying an additional 2,861,880 shares during the last quarter. Swedbank AB bought a new stake in Envista in the 1st quarter worth about $53,412,000. Nuance Investments LLC increased its holdings in Envista by 47.2% in the 2nd quarter. Nuance Investments LLC now owns 7,038,313 shares of the company’s stock worth $117,048,000 after buying an additional 2,256,993 shares in the last quarter. Finally, Ariel Investments LLC raised its position in Envista by 25.3% in the 1st quarter. Ariel Investments LLC now owns 8,892,200 shares of the company’s stock worth $190,115,000 after buying an additional 1,795,258 shares during the last quarter.
Insiders Place Their Bets
In related news, CFO Eric D. Hammes purchased 24,532 shares of Envista stock in a transaction dated Monday, August 12th. The stock was purchased at an average cost of $16.33 per share, for a total transaction of $400,607.56. Following the completion of the acquisition, the chief financial officer now directly owns 24,532 shares of the company’s stock, valued at $400,607.56. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Recommended Stories
- Five stocks we like better than Envista
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Why Micron Could Rally All The Way Through Q4
- What Are Dividend Challengers?
- Should Warren Buffett’s Favorite Stock be Yours Too?
- 3 Warren Buffett Stocks to Buy Now
- Why Buffett Loves Occidental Stock And What It Means for Chevron
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.